OpenEvidence is the leading medical information platform, launched from the Mayo Clinic Platform Accelerate program. It features multimedia and clinical findings from The New England Journal of Medicine, JAMA, and the JAMA Network specialty journals.

Our mission is to organize and expand the world's collective medical knowledge.

OpenEvidence addresses the challenge of information overload in medicine, where the amount of medical research published annually is doubling every 5 years. This makes it nearly impossible for physicians, medical researchers, and healthcare professionals to keep up with the latest research literature and clinical evidence.

To tackle this, OpenEvidence aggregates, synthesizes, and visualizes clinically relevant evidence in understandable and accessible formats to support evidence-based decisions and improve patient outcomes.

The company is supported by leading investors including Sequoia, Google Ventures, Kleiner Perkins, Coatue, Thrive, Conviction, ICONIQ, Greycroft, Breyer Capital, and Mayo Clinic.